| Literature DB >> 30859183 |
Saichit Khummuang1, Kantinan Chuensirikulchai1, Supansa Pata1,2, Witida Laopajon1,2, Nuttapol Chruewkamlow2, Kodchakorn Mahasongkram2, Nobuo Sugiura3, Hideto Watanabe3, Hiroaki Tateno4, Ludthawun Kamuthachad5, Surasakdi Wongratanacheewin5, Nuchjira Takheaw1, Watchara Kasinrerk1,2.
Abstract
Natural killer (NK) cells are innate lymphoid cells having potent cytolytic function that provide host defense against microbial infections and tumors. Using our generated monoclonal antibody (mAb), named FE-1H10, new NK cell sub-populations in peripheral blood were identified. The molecules recognized by mAb FE-1H10 were expressed on a sub-population of CD3-CD56dim NK cells. The epitope recognized by mAb FE-1H10 was demonstrated to be N-glycan and proven to be different from CD57. Upon K562 stimulation, the CD56dimFE-1H10+ NK cell sub-population exhibited significantly lower cytolytic function with low ability to degranulate and release cytolytic granules compared to the CD56dimFE-1H10- NK cell sub-population. Moreover, the CD56dimFE-1H10+ NK cells produced less IFN-γ and TNF-α than the CD56dimFE-1H10- NK cells. We demonstrated here that mAb FE-1H10 could identify two sub-populations of circulating CD56dim NK cells with different functions. Our discovery of new sub-populations of NK cells improves our understanding of NK cell biology and may lead to the development of new approaches for NK cell therapy. © The Japanese Society for Immunology. 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.Entities:
Keywords: cytokine; cytotoxicity; leukocyte surface maker; monoclonal antibody; natural killer cell
Mesh:
Substances:
Year: 2019 PMID: 30859183 DOI: 10.1093/intimm/dxz027
Source DB: PubMed Journal: Int Immunol ISSN: 0953-8178 Impact factor: 4.823